IP Library Assignment 053562/0938
Patent Assignment
Reel/Frame 053562/0938

Assignment of Assignor's Interest

Recorded: 2020-06-08 Pages: 12
Assignor
Assignee
THE INSTITUTE FOR CANCER RESEARCH
333 COTTMAN AVENUE, PHILADELPHIA, PENNSYLVANIA, 19111
Covered Properties (57)
Hepatitis B Virus Compositions and Methods of Use
Yeast Interaction Trap Assay
Patent: 6,326,150 →
Application: 09/508,803 →
Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
Patent: 6,391,557 →
Application: 09/510,322 →
Nucleic Acid Molecule Encoding a Mismatch Endonuclease and Methods of Use Thereof
Patent: 6,699,980 →
Application: 09/514,768 →
Novel Genes Encoding Proteins Involved in Mitotic Checkpoint Control and Methods of Use Thereof
Patent: 6,593,098 →
Application: 09/555,554 →
Methods for Detection of Transition Single-Nucleotide Polymorphisms
Patent: 6,599,700 →
Application: 09/629,222 →
Mpr-Related Abc Transporter Encoding Nucleic Acids and Methods of Use Thereof
Patent: 6,803,184 →
Application: 09/647,140 →
Methods for Identifying Agents Which Affect Cellular Morphology, Locomotion and Death
Patent: 6,653,074 →
Application: 09/669,459 →
Hcg Therapy for the Treatment of Breast Cancer
Patent: 7,183,251 →
Application: 09/868,196 →
Compounds and Methods for Treating Glycogen Storage Disease and Other Pathological Conditions Resulting from Formation of Age-Proteins
Patent: 7,071,298 →
Application: 09/974,323 →
Publication: US 2002/0111291
Compositions and Methods for P53-Mediated Repression of Gene Expression
Patent: 7,053,194 →
Application: 10/108,877 →
Publication: US 2003/0083482
Novel Methods for Inhibiting Angiogenesis
Patent: 7,199,122 →
Application: 10/262,237 →
Publication: US 2003/0100564
Bispecific Single Chain Fv Antibody Molecules and Methods of Use Thereof
Patent: 7,332,580 →
Application: 10/406,830 →
Publication: US 2004/0071696
Methods and cell cultures for promoting organogenesis and tissue development
Patent: 8,802,432 →
Application: 10/487,878 →
Publication: US 2005/0042750
Replication of Hepatitis C Virus in Non-Hepatic Epithelial and Mouse Hepatic Cells
Patent: 7,416,840 →
Application: 10/536,955 →
Publication: US 2006/0128011
High Energy Polyenergetic Ion Selection Systems, Ion Beam Therapy Systems, and Ion Beam Treatment Centers
Patent: 7,317,192 →
Application: 10/559,058 →
Publication: US 2006/0145088
Antibodies Immunologically Specific for a Dna Repair Endonuclease and Methods of Use Thereof
Patent: 7,208,583 →
Application: 10/629,951 →
Publication: US 2004/0018550
Cellular Targets for Treatment of Retroviral Infection
Patent: 7,736,848 →
Application: 11/093,692 →
Publication: US 2006/0024694
Bispecific Single Chain Fv Antibody Molecules and Methods of Use Thereof
Patent: 7,332,585 →
Application: 11/154,103 →
Publication: US 2006/0099205
Genetically Modified Human Natural Killer Cell Lines
Patent: 7,618,817 →
Application: 11/178,258 →
Publication: US 2006/0292156
Anti-Mullerian Inhibiting Substance Type Ii Receptor (Misiir) Immunoconjugates to Detect and Treat Cancer
Patent: 7,781,568 →
Application: 11/327,917 →
Publication: US 2006/0188440
Isoindolone Compounds, Compositions Containing the Same, and Methods of Use Thereof for the Treatment of Viral Infections Related to the Etiology of Cancer
Patent: 7,705,021 →
Application: 11/412,367 →
Publication: US 2006/0264473
Method of Modulating Laser-Accelerated Protons for Radiation Therapy
Patent: 7,268,358 →
Application: 11/445,850 →
Publication: US 2007/0034812
Novel Methods for Inhibiting Angiogenesis
Patent: 7,452,884 →
Application: 11/522,238 →
Publication: US 2007/0015765
Yeast Bacterial Two-Hybrid System and Methods of Use Thereof
Patent: 7,919,610 →
Application: 11/574,378 →
Publication: US 2008/0118919
Laser-Accelerated Proton Therapy Units and Superconducting Electromagnet Systems for Same
Patent: 7,755,068 →
Application: 11/720,873 →
Publication: US 2009/0050819
Novel Gene Encoding a Dna Repair Enzyme and Methods of Use Thereof
Patent: 7,491,807 →
Application: 11/739,558 →
Publication: US 2008/0090763
Bispecific Single Chain Fv Antibody Molecules and Methods of Use Thereof
Patent: 8,329,873 →
Application: 11/943,367 →
Publication: US 2009/0010840
Alternate Morpheeins of Allosteric Proteins as a Target for the Development of Bioactive Molecules
Patent: 7,863,029 →
Application: 12/106,498 →
Publication: US 2008/0286847
Alternate Morpheein Forms of Allosteric Proteins as a Target for the Development of Bioactive Molecules
Patent: 8,153,410 →
Application: 12/142,435 →
Publication: US 2009/0048324
Novel Gene Encoding a Dna Repair Enzyme and Methods of Use Thereof
Patent: 7,829,671 →
Application: 12/354,864 →
Publication: US 2009/0274681
Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
Patent: 8,685,658 →
Application: 12/374,209 →
Publication: US 2009/0306183
Anti-Egfr Family Antibodies, Bispecific Anti-Egfr Family Antibodies and Methods of Use Thereof
Patent: 8,580,263 →
Application: 12/515,522 →
Publication: US 2010/0196265
Hepatitis B Virus Compositions and Methods of Use
Patent: 8,748,373 →
Application: 12/526,759 →
Publication: US 2011/0257080
Genetically Modified Human Natural Killer Cell Lines
Patent: 9,150,636 →
Application: 12/564,255 →
Publication: US 2010/0086486
Genetically Modified Human Natural Killer Cell Lines
Patent: 8,313,943 →
Application: 12/564,283 →
Publication: US 2010/0086996
Method and Apparatus for Endoscopic Examination of Lesions
Patent: 9,451,904 →
Application: 12/579,529 →
Publication: US 2010/0092054
Compositions and Methods for Altering Pancreas or Liver Function
Patent: 8,329,467 →
Application: 12/598,437 →
Publication: US 2010/0129351
Patient Positioning System and Method for Positioning a Patient During a Surgical Procedure
Patent: 9,522,078 →
Application: 12/669,397 →
Publication: US 2010/0288286
Methods and Systems for Increasing the Energy of Positive Ions Accelerated by High-Power Lasers
Patent: 8,269,189 →
Application: 12/742,769 →
Publication: US 2010/0320394
Combinational Chemotherapy Treatment
Patent: 8,617,540 →
Application: 12/760,673 →
Publication: US 2010/0266565
Anti-Mullerian Inhibiting Substance Type Ii Receptor (Misiir) Immunoconjugates to Detect and Treat Cancer
Patent: 8,198,411 →
Application: 12/834,338 →
Publication: US 2010/0278728
Methods for Alleviating Deleterious Effects of 3-Deoxyglucosone
Patent: 8,431,527 →
Application: 12/911,195 →
Publication: US 2011/0034522
Method for the Treatment of Lymphangioleiomyomatosis (Lam)
Patent: 8,530,457 →
Application: 12/989,529 →
Publication: US 2011/0038800
Combination Therapy Based on Src and Aurora Kinase Inhibition for the Treatment of Cancer
Patent: 9,101,631 →
Application: 13/139,441 →
Publication: US 2011/0281935
TetO-p16 Transgenic Mice
Patent: 8,653,324 →
Application: 13/157,477 →
Publication: US 2011/0307967
Inhibition of Activated CDC42-Associated Kinase 1
Patent: 8,658,655 →
Application: 13/429,755 →
Publication: US 2012/0245173
Genetically Modified Human Natural Killer Cell Lines
Patent: 9,181,322 →
Application: 13/651,797 →
Publication: US 2013/0040386
BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF
Patent: 8,980,258 →
Application: 13/710,146 →
Publication: US 2013/0202603
Combination of Dna Repair Inhibition with Bendamustine or Gemcitabine in the Treatment of Cancer
Patent: 8,927,516 →
Application: 13/836,414 →
Publication: US 2013/0303588
Modulators of HSP70/Dnak Function and Methods of Use Thereof
Patent: 9,296,687 →
Application: 14/048,540 →
Publication: US 2014/0087005
Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
Patent: 9,611,321 →
Application: 14/122,286 →
Publication: US 2014/0234213
Combined Inhibition of the Vitamin D Receptor and Dna Replication in the Treatment of Cancer
Patent: 9,265,787 →
Application: 14/140,597 →
Publication: US 2014/0163087
Carbon Nanotube Biosensors and Related Methods
Application: 14/241,671 →
Publication: US 2015/0119263
Novel Fap Inhibitors
Patent: 9,346,814 →
Application: 14/372,798 →
Publication: US 2014/0357650
Genetically Modified Human Natural Killer Cell Lines
Application: 14/836,927 →
Publication: US 2016/0067356
Egfr/NEDD9/Tgf-Beta Interactome and Methods of Use Thereof for the Identification of Agents Having Efficacy in the Treatment of Hyperproliferative Disorders
Application: 15/171,663 →
Publication: US 2017/0002426
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 16, 2001
From: YEUNG, ANTHONY T.
To: FOX CHASE CANCER CENTER
Reel/Frame 011709/0782 →
Assignment of Assignor's Interest Apr 16, 2001
From: YEUNG, ANTHONY T.
To: FOX CHASE CANCER CENTER
Reel/Frame 011706/0481 →
Assignment of Assignor's Interest Jun 14, 2001
From: GOLEMIS, ERICA; SEREBRIISKII, ILYA; KHAZAK, VLADIMIR
To: FOX CHASE CANCER CENTER
Reel/Frame 011892/0599 →
Assignment of Assignor's Interest Jun 18, 2001
From: KRUH, GARY; LEE, KUN; BELINSKY, MARTIN; BAIN, LISA
To: FOX CHASE CANCER CENTER
Reel/Frame 011910/0560 →
Assignment of Assignor's Interest Aug 2, 2001
From: RUSSO, IRMA H.; RUSSO, JOSE; DELUCA, GIAMPIERO; JANSSENS, JAAK
To: FOX CHASE CANCER CENTER; APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V.
Reel/Frame 012366/0809 →
Assignment of Assignor's Interest Mar 1, 2002
From: GOLEMIS, ERICA A.; O'NEILL, GERALDINE; FASHENA, SARAH
To: FOX CHASE CANCER CENTER
Reel/Frame 012666/0472 →
Assignment of Assignor's Interest Apr 29, 2002
From: YEN, TIMOTHY; CHAN, GORDON; JABLONSKI, SANDRA
To: FOX CHASE CANCER CENTER
Reel/Frame 012864/0388 →
Assignment of Assignor's Interest Apr 29, 2002
From: BELLACOSA, ALFONSO
To: FOX CHASE CANCER CENTER
Reel/Frame 012859/0445 →
Assignment of Assignor's Interest Jan 2, 2003
From: RUGGERI, BRUCE A.
To: CEPHALON, INC.
Reel/Frame 013615/0936 →
Assignment of Assignor's Interest Jan 2, 2003
From: CLAPPER, MARGIE L.
To: FOX CHASE CANCER CENTER
Reel/Frame 013615/0951 →
Assignment of Assignor's Interest Apr 5, 2004
From: ADAMS, GREGORY P.
To: FOX CHASE CANCER CENTER
Reel/Frame 015176/0839 →
Assignment of Assignor's Interest Apr 5, 2004
From: HORAK, EVA M.; WEINER, LOUIS M.; MARKS, JAMES D.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 015176/0738 →
Assignment of Assignor's Interest Aug 23, 2004
From: MURPHY, MAUREEN E.
To: FOX CHASE CANCER CENTER
Reel/Frame 015706/0430 →
Assignment of Assignor's Interest Dec 29, 2004
From: ZARET, KENNETH S.; MATSUMOTO, KUNIO; YOSHITOMI, HIDEYUKI
To: FOX CHASE CANCER CENTER
Reel/Frame 016109/0274 →
Assignment of Assignor's Interest Oct 14, 2005
From: DANIEL, RENE; SKALKA, ANNA MARIE; KAO, GARY D.; NUNNARI, GIUSEPPE
To: FOX CHASE CANCER CENTER
Reel/Frame 016644/0039 →
Assignment of Assignor's Interest Nov 30, 2005
From: ZHU, QING; GUO, JU-TAO; SEEGER, CHRISTOPH
To: FOX CHASE CANCER CENTER
Reel/Frame 016830/0872 →
Assignment of Assignor's Interest Feb 22, 2006
From: ADAMS, GREGORY P.
To: FOX CHASE CANCER CENTER
Reel/Frame 017279/0133 →
Assignment of Assignor's Interest Feb 22, 2006
From: HORAK, EVA M.; WEINER, LOUIS M.; MARKS, JAMES D.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 017279/0125 →
Assignment of Assignor's Interest Mar 2, 2006
From: BROWN, TRUMAN R.; KAPPLER, FRANCIS
To: FOX CHASE CANCER CENTER
Reel/Frame 017239/0544 →
Assignment of Assignor's Interest Mar 8, 2006
From: CAMPBELL, KERRY S.
To: FOX CHASE CANCER CENTER
Reel/Frame 017276/0710 →
Assignment of Assignor's Interest Mar 13, 2006
From: CEPHALON
To: FOX CHASE CANCER CENTER
Reel/Frame 017298/0795 →
Confirmatory License Aug 15, 2006
From: FOX CHASE CANCER CENTER
To: US GOVERNMENT - SECRETARY OF THE ARMY
Reel/Frame 018110/0882 →
Assignment of Assignor's Interest Sep 11, 2007
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: LABORATOIRES SERONO SA
Reel/Frame 019966/0026 →
Executive Order 9424, Confirmatory License Dec 18, 2008
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021999/0780 →
Security Agreement Oct 6, 2009
From: ZELLERX CORPORATION
To: MOSKOVITS, DAVID; SCHLESINGER, MICHAEL; ANDREW SCHLESINGER DEFINED BENEFIT PLAN; SPREI, ELI INZLICHT
Reel/Frame 023332/0107 →